Literature DB >> 17716541

Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide.

Walla Al-Hertani1, Sen Rong Yan, David M Byers, Robert Bortolussi.   

Abstract

PURPOSE: Human newborn infants have increased susceptibility to gram-negative bacterial infection. Since lipopolysaccharide (LPS) primes polymorphonuclear neutrophils (PMN) to enhance host defense functions, we investigated its effect on adult and newborn PMN in vitro.
METHODS: PMN were isolated from blood of healthy adults and umbilical cords of full term newborns using dextran and Ficoll-Paque gradient sedimentation. Gel electrophoresis and Western blotting of membranes were used to probe for Mitogen-Activated Protein (MAP) kinase p38 phosphorylation, Toll-like Receptor-4 (TLR-4) and Myeloid Differentiation Factor 88 (MyD88) on isolated PMN membranes using specific antibodies. LPS induced degranulation was assessed using CD66 expression on PMN measured by flow cytometry.
RESULTS: We show that p38 phosphorylation in newborn PMN is attenuated in response to LPS stimulation even though adult and newborn PMN have similar amounts of p38 protein. The degree of attenuation in newborn PMN is dependent on the osmolarity of the medium. In addition, LPS-induced degranulation, a process that is p38 dependent, was also absent in newborn PMN. Although the LPS receptor TLR-4 is present at similar levels on newborn and adult PMN, its downstream adaptor protein MyD88 was significantly diminished in newborn PMN compared to adult cells.
CONCLUSIONS: Although the mechanism of PMN priming by LPS is not fully understood, our results suggest that MyD88 and p38 phosphorylation are important pathways in the process and contribute to attenuated response of newborn PMN to LPS in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716541     DOI: 10.25011/cim.v30i2.979

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  19 in total

1.  Neonatal sepsis and neutrophil insufficiencies.

Authors:  John Nicholas Melvan; Gregory J Bagby; David A Welsh; Steve Nelson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2010-06       Impact factor: 5.311

Review 2.  Impact of maternal HIV exposure, feeding status, and microbiome on infant cellular immunity.

Authors:  Sonwabile Dzanibe; Heather B Jaspan; Michael Z Zulu; Agano Kiravu; Clive M Gray
Journal:  J Leukoc Biol       Date:  2018-12-21       Impact factor: 4.962

Review 3.  Factors influencing the gut microbiome in children: from infancy to childhood.

Authors:  Shreyas V Kumbhare; Dhrati V V Patangia; Ravindra H Patil; Yogesh S Shouche; Nitinkumar P Patil
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

4.  Neutrophil and endothelial adhesive function during human fetal ontogeny.

Authors:  Claudia Nussbaum; Anna Gloning; Monika Pruenster; David Frommhold; Susanne Bierschenk; Orsolya Genzel-Boroviczény; Ulrich H von Andrian; Elizabeth Quackenbush; Markus Sperandio
Journal:  J Leukoc Biol       Date:  2012-12-11       Impact factor: 4.962

Review 5.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way?

Authors:  Zohreh Tatari-Calderone; Naomi L C Luban; Stanislav Vukmanovic
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

7.  Acquisition of adult-like TLR4 and TLR9 responses during the first year of life.

Authors:  Muriel Nguyen; Elke Leuridan; Tong Zhang; Dominique De Wit; Fabienne Willems; Pierre Van Damme; Michel Goldman; Stanislas Goriely
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

Review 8.  Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis.

Authors:  J L Wynn; J Neu; L L Moldawer; O Levy
Journal:  J Perinatol       Date:  2008-09-04       Impact factor: 2.521

Review 9.  Immune responses in neonates.

Authors:  Saleem Basha; Naveen Surendran; Michael Pichichero
Journal:  Expert Rev Clin Immunol       Date:  2014-08-04       Impact factor: 4.473

Review 10.  The developing human preterm neonatal immune system: a case for more research in this area.

Authors:  Ashish Arunkumar Sharma; Roger Jen; Alison Butler; Pascal M Lavoie
Journal:  Clin Immunol       Date:  2012-08-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.